Cargando…

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure

BACKGROUND & AIMS: MicroRNAs (miRNAs) circulate in several body fluids and can be useful biomarkers. The aim of this study was to identify blood-circulating miRNAs associated with cirrhosis progression and acute-on-chronic liver failure (ACLF). METHODS: Using high-throughput screening of 754 miR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaya, Delia, Pose, Elisa, Coll, Mar, Lozano, Juan José, Graupera, Isabel, Schierwagen, Robert, Jansen, Christian, Castro, Pedro, Fernandez, Sara, Sidorova, Julia, Vasa-Nicotera, Mariuca, Solà, Elsa, Caballería, Joan, Trebicka, Jonel, Ginès, Pere, Sancho-Bru, Pau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902550/ https://www.ncbi.nlm.nih.gov/pubmed/33665588 http://dx.doi.org/10.1016/j.jhepr.2021.100233

Ejemplares similares

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes
por: Graupera, Isabel, et al.
Publicado: (2017)

Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis
por: Affò, Silvia, et al.
Publicado: (2015)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells
por: Coll, Mar, et al.
Publicado: (2015)

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
por: Graupera, Isabel, et al.
Publicado: (2022)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections
por: Pose, Elisa, et al.
Publicado: (2021)

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation
por: Casey, Stephen, et al.
Publicado: (2019)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis
por: Ariza, Xavier, et al.
Publicado: (2015)

Current issues in transcatheter aortic valve replacement
por: Mas-Peiro, Silvia, et al.
Publicado: (2020)

SGLT2 inhibitor therapy and pulmonary artery pressure in patients with chronic heart failure—further evidence for improved hemodynamics by continuous pressure monitoring
por: Kirschbaum, Klara, et al.
Publicado: (2021)

Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers
por: Fabrellas, Núria, et al.
Publicado: (2020)

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
por: Sauerbruch, Tilman, et al.
Publicado: (2021)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
por: Alvarez-Silva, Camila, et al.
Publicado: (2019)

Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression
por: Heo, Mi Jeong, et al.
Publicado: (2019)

Portal vein thrombosis in patients with cirrhosis
por: von Köckritz, Leona, et al.
Publicado: (2017)

Percutaneous dual-outflow extracorporeal membrane oxygenation support in secondary right ventricular failure
por: Hecker, Florian, et al.
Publicado: (2022)

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments
por: Herath, Chandana B., et al.
Publicado: (2022)

Effects of the COVID-19 pandemic on the activity of an advanced practice nurse clinic on liver cirrhosis
por: Perez, Martina, et al.
Publicado: (2022)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015)

A Novel Method to Predict Mortality and Length of Stay after Transfemoral Transcatheter Aortic Valve Implantation
por: Zisiopoulou, Maria, et al.
Publicado: (2021)

Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis
por: Queck, Alexander, et al.
Publicado: (2020)

Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023)

New developments in transcatheter therapy of mitral valve disease
por: Walther, Claudia, et al.
Publicado: (2020)

Extracellular Matrix Remodeling in Chronic Liver Disease
por: Ortiz, Cristina, et al.
Publicado: (2021)

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
por: Pieper, Claus Christian, et al.
Publicado: (2021)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Trust is good, control is better: technical considerations in blood microbiome analysis
por: Schierwagen, Robert, et al.
Publicado: (2020)

TLR7‐let‐7 Signaling Contributes to Ethanol‐Induced Hepatic Inflammatory Response in Mice and in Alcoholic Hepatitis
por: Massey, Veronica L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vtia43b9lvbvbndju0rgob7juk